Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy

NCT02072408 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Polypoidal Choroidal Vasculopathy Without Active Polyp

Interventions

DRUG: aflibercept

Sponsor

Samsung Medical Center

Collaborators

[object Object]
[object Object]
[object Object]